| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.52 | 0.004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |